Scholarlink

<p>Early, non-invasive biomarkers for Alzheimer’s disease (AD) are urgently needed. Impaired polyamine metabolism, regulated by intracellular pathways and the gut microbiota, has been reported in postmortem brains of AD patients. Here, we developed a sequential co-extraction workflow (Method 10) that enables recovery of gut bacterial DNA and fecal free polyamines—putrescine, spermidine, and spermine—from the same small mouse fecal sample, allowing paired microbiome and metabolite profiling. Applying this workflow to an AD knock-in mouse model and age-matched controls at 8, 32, and 56 weeks revealed an early decrease in <i>Lactobacillus</i> abundance at 8 weeks accompanied by elevated spermidine levels (<i>p</i> &lt; 0.05), while total fecal polyamine concentrations increased further in AD mice at 56 weeks. These findings suggest that integrated fecal microbiome–polyamine profiling may provide exploratory microbiota–polyamine signatures associated with AD progression.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Sequential co-extraction of gut microbial DNA and fecal polyamines enables integrated microbiome–metabolite profiling in an Alzheimer’s disease mouse model

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月21日

查看全文
  • Shion Akagi,
  • Yuma Sato,
  • Taiichi Sakamoto,
  • Mayumi Minamisawa

摘要

Early, non-invasive biomarkers for Alzheimer’s disease (AD) are urgently needed. Impaired polyamine metabolism, regulated by intracellular pathways and the gut microbiota, has been reported in postmortem brains of AD patients. Here, we developed a sequential co-extraction workflow (Method 10) that enables recovery of gut bacterial DNA and fecal free polyamines—putrescine, spermidine, and spermine—from the same small mouse fecal sample, allowing paired microbiome and metabolite profiling. Applying this workflow to an AD knock-in mouse model and age-matched controls at 8, 32, and 56 weeks revealed an early decrease in Lactobacillus abundance at 8 weeks accompanied by elevated spermidine levels (p < 0.05), while total fecal polyamine concentrations increased further in AD mice at 56 weeks. These findings suggest that integrated fecal microbiome–polyamine profiling may provide exploratory microbiota–polyamine signatures associated with AD progression.